Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CASP2 | P42575 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL12476946 | 1.00 | ALDH1A1 (0.55) | ALDH1A1SMN1; SMN2TSHRTDP1NAPRT | |
| Pyridine SCHEMBL8606542 | 0.98 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2TSHRTDP1NAPRT | |
| Pyridine SCHEMBL618965 | 0.98 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2TSHRTDP1NAPRT | |
| Benzene SCHEMBL6273750 | 0.98 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2TSHRTDP1NAPRT | |
| Pyridine SCHEMBL11779483 | 0.98 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2TSHRTDP1NAPRT | |
| Pyridine SCHEMBL10539991 | 0.95 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2TSHRTDP1NAPRT | |
| 1-Pentanol SCHEMBL27902508 | 0.93 | SMN1; SMN2 (0.57) | ALDH1A1SMN1; SMN2TSHRTDP1NAPRT | |
| Pyridine SCHEMBL7422031 | 0.91 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2TSHRTDP1NAPRT | |
| 1-Pentanol SCHEMBL9404714 | 0.91 | SMN1; SMN2 (0.55) | ALDH1A1SMN1; SMN2TSHRTDP1NAPRT | |
| Cetyl Alcohol SCHEMBL6680914 | 0.91 | LMNA (0.59) | ALDH1A1SMN1; SMN2TSHRTDP1NAPRT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108484487-B | Antibacterial (methyl) acrylate monomer containing quaternary pyridinium salt and carbamate structure and preparation method and application thereof | 华南理工大学 | 2021-10-22 | — | — | CN | claimed |
| CN-111233748-A | Synthesis of tirofiban hydrochloride | 海门慧聚药业有限公司 | 2020-06-05 | — | — | CN | claimed |
| CN-102285912-A | Method for preparing N-n-butylsulfonyl-O-(4-(4-pyridyl)-butyl)-L-tyrosine alkyl ester | — | 2011-12-21 | — | — | CN | claimed |
| CN-102260208-A | New preparation process of 4-pyridine butanol | — | 2011-11-30 | — | — | CN | claimed |
| US-20040072790-A1 | Safe natural pharmaceutical composition for treating cancer | LIU YAGUANG (US) | 2004-04-15 | — | — | US | claimed |
| US-5834605-A | SOLVENT EXTRACTION OF DAIDZIN AND GENISTIN FROM PUERARIA OR SOYBEAN SEEDS; VACUUM DISTILLATION, CHROMATOGRAPHY USING FIRST A BUTANOL AND THEN A BUTANOL/PYRIDINE DEVELOPER, AND RECRYSTALLIZATION | LIU YAGUANG (US) | 1998-11-10 | — | — | US | claimed |
| US-4985408-A | PRODUCING PUERARIN FROM PLANT ROOTS | LIU YAGUANG (US) | 1991-01-15 | — | — | US | claimed |
| US-4133804-A | MULTISTAGE, DIALYSIS, FILTRATION AND CHROMATOGRAPHING OF BLOOD SERUM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1979-01-09 | — | — | US | claimed |
| CN-115947680-B | Tirofiban intermediate compound and preparation method thereof | 山东新时代药业有限公司 | 2025-09-23 | — | — | CN | disclosed |
| CN-115181058-B | Composition and quality control method thereof | 武汉武药科技有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-115947680-A | Tirofiban intermediate compound and preparation method thereof | 山东新时代药业有限公司 | 2023-04-11 | — | — | CN | disclosed |
| WO-2023038506-A1 | COMPOSITION CONTAINING FOXTAIL EXTRACT AS ACTIVE INGREDIENT, AND USE THEREOF | 경북대학교 산학협력단 | 2023-03-16 | — | — | WO | disclosed |
| WO-2023038287-A1 | COMPOSITION, FOR PREVENTING, RELIEVING, OR TREATING MUSCLE WEAKNESS-RELATED DISEASE, COMPRISING CELERY SEED EXTRACT AS ACTIVE INGREDIENT | 경북대학교 산학협력단 | 2023-03-16 | — | — | WO | disclosed |
| CN-115772116-A | Tirofiban intermediate compound | 山东新时代药业有限公司 | 2023-03-10 | — | — | CN | disclosed |
| US-4312857-A | ANALGESICS, ANTIDEPRESSANTS, SEDATIVES, TRANQUILIZERS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE VETERANS ADMINISTRATION (US) | 1982-01-26 | — | — | US | disclosed |
| US-4162305-A | Antibiotic XK-99 and process for production thereof | ABBOTT LABORATORIES (US) | 1979-07-24 | — | — | US | disclosed |
| US-4148886-A | TREATMENT OF AUTOIMMUNE DISEASES | Institute National de la Sante & de la Recherche Medicale (INSERM) (FR) | 1979-04-10 | — | — | US | disclosed |
| US-4133804-A | MULTISTAGE, DIALYSIS, FILTRATION AND CHROMATOGRAPHING OF BLOOD SERUM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1979-01-09 | — | — | US | disclosed |
| US-4107424-A | ANTIBACTERIAL | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1978-08-15 | — | — | US | disclosed |
| US-4021387-A | PARASITICIDES, ANAPHYLAXIS, BRONCHIAL ASTHMA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1977-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040072790-A1 | Safe natural pharmaceutical composition for treating cancer | MATR3, HPN, HAMP | ALDH1A1 1635/4885SMN1; SMN2 4152/4885TSHR 4701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.